evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
18930,GENE_SUMMARY,,"PREX2, a positive mediator of RAC1 GTPase, is predominantly mutated in melanomas.",,2017-03-28,,80243,PREX2,"phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2",False,ENST00000288368,NM_024870.2,PPP1R129,DEP.2,P-REX2,DEPDC2,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18931,GENE_BACKGROUND,,"The PREX2 gene encodes a protein that facilitates the exchange of GDP to GTP on RAC1, leading to the activation of its downstream effectors. PREX2 is activated by phosphatidylinositol 3,4,5-trisphosphate (PIP3) and G-protein coupled receptors and mediates the PI3K pathway-dependent activation of RAC1 (PMID: 15304343, 15304342, 15897194). PREX2 can activate the PI3-Kinase (PI3K) pathway by antagonizing PTEN inhibitory effects (PMID: 19729658); conversely, PTEN negatively regulates PREX2-mediated oncogenic effects (PMID: 25829446). PREX2 activation increases cell proliferation, activates PI3K signaling and downregulates tumor suppressors such as CDKN1C in NRAS-mutant melanoma (PMID: 25829446, 26884185). Oncogenic effects of PREX2 have also been described in other cancers (PMID: 26718453), as well as a role for PREX2 in the insulin signaling pathway (PMID: 26438819). PREX2 is mutated in melanomas and other skin cancers, as well as in pancreatic tumors (PMID: 22622578, 25719666; cBioPortal, MSKCC, Dec. 2016).",,2017-03-28,,80243,PREX2,"phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2",False,ENST00000288368,NM_024870.2,PPP1R129,DEP.2,P-REX2,DEPDC2,False,25829446,PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion.,Science signaling,2018-03-31T20:15:00,8,370,ra32,Mense SM et al,doi: 10.1126/scisignal.2005840,,0001-03-31,,26438819,p21-activated Kinases (PAKs) Mediate the Phosphorylation of PREX2 Protein to Initiate Feedback Inhibition of Rac1 GTPase.,The Journal of biological chemistry,2017-11-27T20:15:00,290,48,28915-31,Barrows D et al,doi: 10.1074/jbc.M115.668244,,0001-11-27,,15304343,"P-Rex2, a new guanine-nucleotide exchange factor for Rac.",FEBS letters,2018-08-13T20:04:00,572,2001-01-03,172-6,Donald S et al,,,2002-01-03,,25719666,Whole genomes redefine the mutational landscape of pancreatic cancer.,Nature,2018-02-26T20:15:00,518,7540,495-501,Waddell N et al,doi: 10.1038/nature14169,,2018-02-26T05:01:00,,15304342,"P-REX2, a novel PI-3-kinase sensitive Rac exchange factor.",FEBS letters,2018-08-13T20:04:00,572,2001-01-03,167-71,Rosenfeldt H et al,,,2002-01-03,,22622578,Melanoma genome sequencing reveals frequent PREX2 mutations.,Nature,2018-05-09T20:12:00,485,7399,502-6,Berger MF et al,doi: 10.1038/nature11071,,0001-05-09,,19729658,Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.,"Science (New York, N.Y.)",2018-09-04T20:09:00,325,5945,1261-5,Fine B et al,doi: 10.1126/science.1173569,,0001-09-04,,26884185,Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma.,Proceedings of the National Academy of Sciences of the United States of America,2018-03-01T20:16:00,113,9,E1296-305,Lissanu Deribe Y et al,doi: 10.1073/pnas.1513801113,,2018-03-01T03:05:00,,15897194,Substrate specificity and recognition is conferred by the pleckstrin homology domain of the Dbl family guanine nucleotide exchange factor P-Rex2.,The Journal of biological chemistry,2018-07-29T20:05:00,280,30,27508-12,Joseph RE et al,,,0001-07-29,,26718453,Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells.,Molecular medicine reports,2018-02-01T20:16:00,13,2,1930-6,Dai Z et al,doi: 10.3892/mmr.2015.4728,,0001-02-01,
